Related Experiment Video

Updated: May 10, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.2K

Hypersensitivity to Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia and Management With

Jason Catanzaro1, John van Doorninck2, Mariana Castells3,4

  • 1National Jewish Health, Denver, Colorado, USA.

Pediatric Blood & Cancer
|April 24, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.5K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.1K

Related Experiment Videos

Last Updated: May 10, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.2K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.5K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.1K

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

377
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
377
Allergic Reactions02:06

Allergic Reactions

27.1K
Overview
27.1K
Cross-reactivity00:42

Cross-reactivity

30.9K
Overview
30.9K

Articles linked to this work by shared authors, journal, and citation graph.

Mast cell activation syndrome: Global perspectives from a World Allergy Organization survey on knowledge, diagnosis, and access to care.

The World Allergy Organization journal·2026

Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper.

Allergy·2026

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Respiratory Viruses, Self-Diagnosis, Early Treatment and Prophylaxis.

Viruses·2026

Anaphylaxis and Epinephrine Use in Pregnancy.

The journal of allergy and clinical immunology. In practice·2026

Functional validation of PIK3R1 variant causing activated phosphoinositide 3-kinase-δ syndrome 2 with hypogammaglobulinemia and bronchiectasis.

Journal of human immunity·2026

Feeding, Fear, and Acceptance: Caregivers' Experiences of Nutritional Support During Childhood Cancer Treatment.

Pediatric blood & cancer·2026

Neurocognitive, School-Based, and Quality of Life Outcomes for Youth With Sickle Cell Disease and Thalassemia: A Scoping Review.

Pediatric blood & cancer·2026

Elevated Blood Lead Levels in Children With Sickle Cell Disease.

Pediatric blood & cancer·2026

Conquering Infant and Young Children Medulloblastoma in Resource-Limited Settings: Challenges, Opportunities, and Treatment Outcomes.

Pediatric blood & cancer·2026

Cell-Sorted EBV PCR Identifies Lineage Shift and Guides Management After Hematopoietic Cell Transplantation for Pediatric EBV-Positive T/NK-Cell Lymphoid Neoplasia: A Case Series.

Pediatric blood & cancer·2026

Clinical Characteristics of Intracranial Hemorrhage in Pediatric Acute Leukemia.

Pediatric blood & cancer·2026

Multiplex IgE reactivity without a documented corresponding phenotype: cross-sectional patterns and routine-care follow-up.

European annals of allergy and clinical immunology·2026

Colchicine for refractory palisading and neutrophilic granulomatous dermatitis associated with mixed connective tissue disease.

Proceedings (Baylor University. Medical Center)·2026

Integrative Network Analysis and Machine Learning Identify Cell Adhesion-Related Biomarkers and Immune Heterogeneity in Allergic Rhinitis.

Immunity, inflammation and disease·2026

Topical Remibrutinib Attenuates LL37-Induced Rosacea-Like Dermatitis by Inhibiting BTK Activation, NF-κB Signaling and Mast Cell Activation.

Journal of inflammation research·2026

Clinical and Immunological Associations of Anti-Ro52 Antibody Positivity in Primary Sjögren Disease: A Retrospective Cross-Sectional Study.

Journal of inflammation research·2026

Investigation of Clinical and Immunological Features of Alopecia Areata With Comorbid Atopic Dermatitis.

Allergy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us